Increased risk of superficial fungal infections among psoriasis patients receiving systemic treatment: A nationwide retrospective population-based cohort study-Reference-Cited by-同舟云学术

Increased risk of superficial fungal infections among psoriasis patients receiving systemic treatment: A nationwide retrospective population-based cohort study

Published:2024-04-04 Issue: Volume: Page:
ISSN:
Container-title:
language:
Short-container-title:

Author:

Seo Ji-In¹,Kim Hasung²,Lee Jungkuk²,Ahn Hye-Jin¹,Jeong Ki-Heon¹,Shin Min Kyung¹

Affiliation:

1. Kyung Hee University College of Medicine, Kyung Hee University Hospital

2. Hanmi Pharmaceutical (South Korea)

Abstract

Previous meta-analyses or large cohort studies of risk for onychomycosis or mucocutaneous candidiasis in psoriasis patients has been reported. We conducted the retrospective nationwide population-based cohort study to assess the incidence and risk of superficial fungal infections among patients with psoriasis receiving systemic treatment. Our study showed an increased risk of superficial fungal infection among patients with psoriasis receiving systemic treatment regardless of treatment type.

Publisher

Research Square Platform LLC

Reference5 articles.

1. Coexistence of onychomycosis and nail psoriasis and its correlation with systemic treatment;Grynszpan R;Mycoses,2021

2. The prevalence of onychomycosis in psoriatic patients: a systematic review;Klaassen KM;J Eur Acad Dermatol Venereol,2014

3. Evaluation of Candidal colonization and specific humoral responses against Candida albicansin patients with psoriasis;Taheri Sarvtin M;International Journal of Dermatology,2014

4. Candida infections in patients with psoriasis and psoriatic arthritis treated with interleukin-17 inhibitors and their practical management;Rodríguez-Cerdeira C;Ital J Dermatol Venerol,2021

5. Blockade of the IL-17 signaling pathway increased susceptibility of psoriasis patients to superficial fungal infections;Hiruma J;J Dermatol Sci.,2021